You searched for "laser"

4818 results found

Management considerations for limited usable hearing unilaterally in the paediatric population

How can we best support children with limited usable hearing in one ear? This article discusses the latest approaches. Limited usable hearing unilaterally (LUHU) is an emerging term and has been suggested to replace the historical term ‘single-sided deafness (SSD)’....

Developing an Innovation for ENT – from Idea to Market: how ‘e-i’ did it

Background endoscope-i (e-i) Ltd was incorporated into Companies House on December 3rd, 2012 following eight months of developing our first project, a simple iPhone adapter for endoscopes. Of the three founding shareholders, two are ENT surgeons and one a lecturer...

Minimum stimulus strategy for the diagnosis of BPPV

Explore the innovative minimum stimulus strategy (MSS) for diagnosing benign paroxysmal positional vertigo (BPPV), enhancing accuracy while minimising patient discomfort. Benign paroxysmal positional vertigo (BPPV) is a common vestibular disorder where canalolithiasis or cupulolithiasis causes sudden episodes of vertigo, triggered...

Diagnosis of obstructive sleep apnoea hypopneoa syndrome (OSAHS) without sleep studies

Polysomnography is considered the ‘gold standard’ in the diagnosis of sleep apnoea but it is expensive and difficult to perform in children. Diagnosis based on subjective judgement is often inaccurate. An accurate diagnostic scale based on clinical parameters could obviate...

Clonidine based vs Remifentanil based hypotensive anaesthesia in FESS

A study investigating the use of clonidine preoperatively in FESS surgery. A double blinded trial of 47 patients in Barcelona randomised into receiving clonidine (20 minutes preoperatively) versus Remifentanil (continuous infusion). Propofol and fentanyl were used for induction and then...

From the editor MarApr 2020

Declan Costello, MA, MBBS, FRCS(ORL-HNS), Editor, ENT & Audiology News; Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.net As I write this editorial, the world is holding its breath while it follows the coronavirus...

‘Dead ear’ after mastoid surgery

The primary aim of surgery in the management of cholesteatoma is eradication of the disease which can potentially result in serious complications such as intracranial extension, facial nerve weakness and further hearing loss. A profound hearing loss resulting postoperatively considerably...

Food impaction in children is associated with eosinophilic oesophagitis

There is an increasing amount of evidence to suggest that chronic oesophageal inflammation and motility disorders play a more significant role in oesophageal food impaction (EFI) in children compared to structural defects. The authors conducted a retrospective study of children...

Genomic testing for deafness and its implications

Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...

Bell’s palsy incidence in Korean population

Bell’s palsy is an acute idiopathic paresis or paralysis of the peripheral facial nerve. It is the most common cause of facial nerve palsy with a reported incidence ranging from 11.5–55.3 per 100,000. The aetiology remains unclear. Several studies have...

The ACS-NSQIP study – predictive risk factors and outcomes in primary malignant parotid tumour surgery

Malignant parotid gland tumours occupy a good proportion of the ENT surgeon’s operative caseload. Large standardised datasets for malignant parotid tumour surgery are limited. This international multi-institutional study is based on the pooled American College of Surgeons National Surgical Quality...

Adjoin™ bone conduction system

Patrik Westerkull (PW), Otorix AB, and Ann-Louise McDermott (A-LM), ENT Consultant at Birmingham Children’s Hospital, tell us about the Adjoin bone conduction device, a non-surgical bone-conduction option developed by Otorix. They explain how the product works, the background to the...